Document Detail


The prognosis of tardive dyskinesia.
MedLine Citation:
PMID:  6133847     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Reexamination of the prognosis of tardive dyskinesia indicates that the concept of irreversibility should be replaced by a focus on longitudinal changes. Factors involved in the etiology and point prevalence of TD (e.g., neuroleptic exposure) are not necessarily the determinants of outcome. The presence of affective disorder and poor response to treatment in chronic psychotic patients appear to be related to poor prognosis. Severe dyskinesia with functional impairment is rare. Such severe cases are more likely to show a rapidly developing malignant course than to be the end result of slowly progressing TD after many years of neuroleptic treatment.
Authors:
G Gardos; J O Cole
Related Documents :
22859697 - The spectrum of neuromyelitis optica (nmo) in childhood.
15210487 - Dyskinesias and associated psychiatric disorders following streptococcal infections.
19302937 - Scale for evaluation of movement disorders in the first three years of life.
2547027 - Neuropathology in movement disorders.
24362847 - Evidence of association between snap25 gene and attention deficit hyperactivity disorde...
12120117 - Dyspepsia, irritable bowel syndrome, and constipation: review and what's new.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Journal of clinical psychiatry     Volume:  44     ISSN:  0160-6689     ISO Abbreviation:  J Clin Psychiatry     Publication Date:  1983 May 
Date Detail:
Created Date:  1983-07-08     Completed Date:  1983-07-08     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  7801243     Medline TA:  J Clin Psychiatry     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  177-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Adult
Age Factors
Aged
Antipsychotic Agents / adverse effects
Dyskinesia, Drug-Induced / diagnosis*,  etiology
Female
Humans
Male
Middle Aged
Outcome and Process Assessment (Health Care)
Prognosis
Schizophrenia / drug therapy
Time Factors
Grant Support
ID/Acronym/Agency:
MH-32675/MH/NIMH NIH HHS
Chemical
Reg. No./Substance:
0/Antipsychotic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Incorporation of radioactivity from amino acids in the presence of cycloheximide demonstrates glucon...
Next Document:  ECT in the neuroleptic malignant syndrome: case report.